Weight loss reduces tissue factor in morbidly obese patients (Q44548928)

4 December 2017

Weight loss reduces tissue factor in morbidly obese patients (English)

1 reference

4 December 2017

0 references

Christoph W Kopp

1

1 reference

4 December 2017

Hans-Peter Kopp

2

1 reference

4 December 2017

Sabine Steiner

3

1 reference

4 December 2017

Stephan Kriwanek

4

1 reference

4 December 2017

Katarzyna Krzyzanowska

5

1 reference

4 December 2017

Andrea Bartok

6

1 reference

4 December 2017

Rudolf Roka

7

1 reference

4 December 2017

Erich Minar

8

1 reference

4 December 2017

Guntram Schernthaner

9

1 reference

4 December 2017

1 August 2003

1 reference

4 December 2017

1 reference

4 December 2017

11

1 reference

4 December 2017

8

1 reference

4 December 2017

950-956

1 reference

Regulation of tissue factor gene expression in obesity

4 December 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Hemostatic function in young subjects with central obesity: relationship with left ventricular function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Intentional weight loss and mortality among overweight individuals with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mellitus: influence of type of diabetes, obesity index, and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Do atherosclerosis and type 2 diabetes share a common inflammatory basis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

High-dose leptin activates human leukocytes via receptor expression on monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

The adipocyte and hemostatic balance in obesity: studies of PAI-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Tissue factor gene expression in the adipose tissues of obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Mechanism on disorders of coagulation and fibrinolysis in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Body composition assessment in extreme obesity and after massive weight loss induced by gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Tumour necrosis factor-alpha, inflammatory biomarkers, and atherogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Vertical gastroplasty: evolution of vertical banded gastroplasty

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

The fat mouse. A powerful genetic model to study hemostatic gene expression in obesity/NIDDM.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Tissue factor pathway inhibitor activity in patients with IDDM

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Effect of Advanced Glycation End Product–Modified Albumin on Tissue Factor Expression by Monocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Transcriptional regulation of transforming growth factor beta1 by glucose: investigation into the role of the hexosamine biosynthesis pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

Initiation of coagulation by tissue factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.131

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2003.131

1 reference

4 December 2017

1 reference